Opioid Prescription Verification Act of 2021
Latest action · Dec 9, 2021 Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Progress
Where this bill reached, and when. A stage with no date was not reached; one that failed a vote and later carried shows the date it carried.
- IntroducedApr 5, 2021
- Passed HouseDec 8, 2021
- Passed SenateNot reached
- To the PresidentNot reached
- Became lawNot reached
Summary
Opioid Prescription Verification Act of 2021
This bill modifies overdose prevention activities carried out by the Department of Health and Human Services (HHS) and the Centers for Disease Control and Prevention (CDC).
Specifically, HHS must update pharmacist training materials to include information about how to verify the identity of patients who are prescribed medications.
In addition, the CDC may give preference, in awarding grants for overdose prevention, to states that
- maintain a prescription drug monitoring program that mandates the collection of specified information,
- require prescribers of certain potentially addictive medications to issue prescriptions electronically (subject to some exceptions), and
- require dispensers of certain potentially addictive medications to enter particular information about the purchase of such medications into their state's prescription drug monitoring program.
Recorded votes 1
Newest first. Open one to see how every member voted.
| Roll call | Question | Result | Date |
|---|---|---|---|
| House 422 | On Motion to Suspend the Rules and Pass, as Amended | Passed410–15 | Dec 8, 2021 |
Cosponsors 8
Members who signed on, in the order they did. Signatures ran from Apr 5, 2021 to Aug 13, 2021; 2 are original cosponsors, there from the day it was introduced.
| Seat | Cosponsor | Signed on | |
|---|---|---|---|
| R-MO | Ann Wagner | Original | Apr 5, 2021 |
| R-FL | Gus M. Bilirakis | Original | Apr 5, 2021 |
| R-IL | Adam Kinzinger | Apr 8, 2021 | |
| R-WV | Alexander X. Mooney | Apr 8, 2021 | |
| R-OH | Michael R. Turner | Apr 8, 2021 | |
| R-CA | Doug LaMalfa | Apr 14, 2021 | |
| R-FL | Scott Franklin | Apr 14, 2021 | |
| R-NC | Ted Budd | Aug 13, 2021 |
Committees 2
Where it was sent and what each committee and subcommittee did with it, in order.
| Chamber | Committee | What it did |
|---|---|---|
| House | Energy and Commerce Committee | Referred Apr 5, 2021Markup Jul 21, 2021Reported Nov 30, 2021 |
| Health Subcommittee | Referred Apr 13, 2021Markup Jul 15, 2021Reported Jul 15, 2021 | |
| Senate | Health, Education, Labor, and Pensions Committee | Referred Dec 9, 2021 |
Actions 16
Everything that happened, newest first.
- Dec 9, 2021Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
- Dec 8, 2021Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by the Yeas and Nays: (2/3 required): 410 - 15 (Roll no. 422). (consideration: CR H7540-7541)
- Dec 8, 2021Motion to reconsider laid on the table Agreed to without objection.
- Nov 30, 2021Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 117-180.
- Nov 30, 2021Placed on the Union Calendar, Calendar No. 130.
- Nov 30, 2021Mr. Pallone moved to suspend the rules and pass the bill, as amended.
- Nov 30, 2021Considered under suspension of the rules. (consideration: CR H6691-6693; text: CR H6691)
- Nov 30, 2021DEBATE - The House proceeded with forty minutes of debate on H.R. 2355.
- Nov 30, 2021At the conclusion of debate, the Yeas and Nays were demanded and ordered. Pursuant to the provisions of clause 8, rule XX, the Chair announced that further proceedings on the motion would be postponed.
- Jul 21, 2021Committee Consideration and Mark-up Session Held.
- Jul 21, 2021Ordered to be Reported (Amended) by Voice Vote.
- Jul 15, 2021Subcommittee Consideration and Mark-up Session Held.
- Jul 15, 2021Forwarded by Subcommittee to Full Committee (Amended) by Voice Vote .
- Apr 13, 2021Referred to the Subcommittee on Health.
- Apr 5, 2021Introduced in House
- Apr 5, 2021Referred to the House Committee on Energy and Commerce.
In the Congressional Record 4
Days the Record’s own index lists this bill, newest first, with the pages and the members it names. Pages starting H are the House, S the Senate, E Extensions of Remarks.
| Where | In the Record | Members | Date |
|---|---|---|---|
| House | Recorded votes H7540enactLists H7541Votes recorded by proxy on H.R. 2355, Opioid Prescription Verification Act | — | Dec 8, 2021 |
| Extensions | Debate and remarks E1292 | Anna G. Eshoo D-CA | Dec 1, 2021 |
| House | Debate and remarks H6691–H6693Text printed H6691 | Brett Guthrie R-KY, Frank Pallone, Jr. D-NJ, Gus M. Bilirakis R-FL, Rodney Davis R-IL | Nov 30, 2021 |
| House | Lists H1713H.R. 2355–2376 | — | Apr 5, 2021 |
Research
What has been written about this bill: committee reports, cost estimates, the sponsor’s authority statement, printed hearings and the Congressional Research Service’s work.
Committee report
Congressional Budget Office cost estimate
- Sep 22, 2021H.R. 2355, Opioid Prescription Verification Act of 2021As ordered reported by the House Committee on Energy and Commerce on July 21, 2021
Constitutional authority
The sponsor’s statement, as printed in the Congressional Record, vol. 167, no. 60, April 5, 2021, page H1713.
Printed hearings 1
Hearings whose printed record names this bill, newest first: hearings on it, and wider hearings where it came up.
| Number | Hearing | Committee | Held |
|---|---|---|---|
| Serial No. 117-20 | AN EPIDEMIC WITHIN A PANDEMIC: UNDERSTANDING SUBSTANCE USE AND MISUSE IN AMERICA327 pages | Energy and Commerce Committee | Apr 14, 2021 |
Related bills 1
Companion bills and other measures the record links to this one.
| Bill | Title | Relationship | Latest action |
|---|---|---|---|
| HR 4810 | Opioid Prescription Verification Act of 2019 | Reintroduction of | Oct 26, 2019 |
Titles 5
Every title it has carried, official and short, at each stage.
- Official Title as Introduced
- To facilitate responsible, informed dispensing of controlled substances and other prescribed medications, and for other purposes.
- Short Title(s) as Introduced
- Opioid Prescription Verification Act of 2021
- Short Title(s) as Reported to House
- Opioid Prescription Verification Act of 2021
- Short Title(s) as Passed House
- Opioid Prescription Verification Act of 2021
- Short Titles from RFS (Referred to Senate) bill text
- Opioid Prescription Verification Act of 2021
Subjects
Assigned by the Library of Congress. Policy area: Health.
Text 4
Each version as it was printed, newest first.
- Dec 9, 2021Referred in Senate
- Dec 8, 2021Engrossed in House
- Nov 30, 2021Reported in House
- Apr 5, 2021Introduced in House
Everything here is as published by Congress: the summary is the Congressional Research Service's, the action wording is the clerks', and the subjects are the Library of Congress's. How far it got is read from the actions themselves, taking the most recent one of each kind, so a bill that failed a vote and later passed is shown as having passed. Records come from this bill on Congress.gov and govinfo.gov; cost estimates are the Congressional Budget Office's, and the hearings are the printed hearings GovInfo publishes, which can appear months after the hearing.
